About: The Chance of Permanent Cure for Micro- and Macroprolactinomas, Medication or Surgery? A Systematic Review and Meta-Analysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The Chance of Permanent Cure for Micro- and Macroprolactinomas, Medication or Surgery? A Systematic Review and Meta-Analysis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article by Qianquan Ma et al published 2018 in Frontiers in Endocrinology

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у 2018 (uk) article scientifique publié en 2018 (fr) im Jahr 2018 veröffentlichter wissenschaftlicher Artikel (de) scholarly article by Qianquan Ma et al published 2018 in Frontiers in Endocrinology (en)
publication date	wds:Q58556107-BD1FED90-4D08-49DD-A500-A05C049EFEE8
publication date	2018-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58556107-C32BB0CD-5C60-495E-AE1A-387F317DFA9C
language of work or name	English
cites work	wds:Q58556107-00EB65D3-2CE7-46D7-8991-F1CF9446FDAB wds:Q58556107-0658E8AC-5CF4-4505-8864-E696CF27B1C7 wds:Q58556107-0BF1980D-73AE-4866-B74B-1C89FFD5CBF9 wds:Q58556107-0E813EDA-E993-4C6B-AAB3-BDDF39CC2CF2 wds:Q58556107-1795D4FD-C1EF-4DE5-B549-C3B6623A5102 wds:Q58556107-1F9F86D1-4E00-4871-BB40-AE41F3E0B5F3 wds:Q58556107-22E99CC7-7537-483A-B7B2-5EC12F7C3B1A wds:Q58556107-33315AB2-ABAC-4EBB-A556-9A296CA9D4DA wds:Q58556107-34F300C4-8E33-4DBC-AAAD-991F737A05C2 wds:Q58556107-34FF94BC-24BD-4E48-8EA6-C9FE94974CD1 wds:Q58556107-3A0A6315-D0B7-4582-BA6A-7C95B8EF588B wds:Q58556107-3C2C83DD-3FF9-43EE-B792-E74CAF767AF8 wds:Q58556107-404332A5-592C-4589-8861-E2654C6AB14D wds:Q58556107-4559D7F1-5AD8-4604-9FFD-175606A49D5E wds:Q58556107-4C47654D-9108-4634-B215-3D60A4F6FFBC wds:Q58556107-4EA45B31-C103-44EC-AB57-A5C7904481BC wds:Q58556107-62BE9966-3218-4606-BFE6-9C9248D2A402 wds:Q58556107-64EF379A-6BC5-4A35-9BFF-B8E24DAE6D85 wds:Q58556107-6A65173E-EB47-4E97-86C6-9119EB207000 wds:Q58556107-6BF06DC7-E601-4AC7-BD99-154EA69381F1 wds:Q58556107-6D46BBBD-78E3-439F-BCAC-9D00B6BB3AA9 wds:Q58556107-74B9D31B-E1F7-46D7-8274-4F039BDAB778 wds:Q58556107-764C161A-3A45-4703-BBA2-D7099D69E0E9 wds:Q58556107-79984A73-5DD5-46B1-B421-0726A8B49C88 wds:Q58556107-7A9326BB-60AF-415B-B4B8-27BC9176F08B wds:Q58556107-7DBCF8E4-E039-472C-8948-418154A99E03 wds:Q58556107-8B86B063-E1AF-446D-B9A1-D8E21EF6AE5C wds:Q58556107-8CE81AE2-D992-44BA-821D-C3F496A8137C wds:Q58556107-8E651B9F-6976-477F-BE7D-3EFF4B0AAF0C wds:Q58556107-9FB0CC8F-C8A5-4631-A6D1-BA77A7ACE9B1 wds:Q58556107-A6B95DC2-E666-4689-B444-8FC29C62638A wds:Q58556107-A8AA3B49-F01D-4EC4-AD5A-890DE20A949D wds:Q58556107-AC3DDA20-9FF5-4E77-9A1D-3EB286F5CB7D wds:Q58556107-AF7D82FA-489E-42F6-9F1E-E6A9501B0293 wds:Q58556107-B8CE9587-0061-41F3-9A49-DF93C5580E25 wds:Q58556107-BAF17AFF-17AB-43C4-AA56-A35A04D4F806 wds:Q58556107-BBA8DC9D-7275-45CD-8010-B6727445F223 wds:Q58556107-BC3341EE-EA12-4457-AC80-5607D15E0D15 wds:Q58556107-BDC9013B-2622-4C72-9B49-FA878B3801DE wds:Q58556107-C1ADF930-B80F-48F5-A7B6-BA77CCF1FB99 wds:Q58556107-C43AFDB7-0D74-4F9C-B85E-F43F619A39C6 wds:Q58556107-C4A227C9-80B5-41ED-83E0-2BA44C0C8C3E wds:Q58556107-C61EF041-E201-4463-AAA3-4AC3FAC3C751 wds:Q58556107-CAEF521C-7494-4544-9EA6-8E6EB070D9AD wds:Q58556107-CBD3E97B-9094-4394-9F54-C4F5DCF0E520 wds:Q58556107-D4A18174-2F7E-4B36-AFEE-D5813D8C9C0B wds:Q58556107-D89123F7-67D2-451B-BC7B-0BCA3F9C5F6D wds:Q58556107-D920008A-BAD0-4C66-AE31-40FFC6810AD8 wds:Q58556107-DADA8FE4-3668-46BF-B530-CE001A7FDD91 wds:Q58556107-E3E24397-A97A-4BBE-84BF-BE459A68AAF0 wds:Q58556107-E4685671-1083-4E9C-B35F-F0FF7C99ACA7 wds:Q58556107-EDC0D6CF-1CCB-4EBB-94AD-6C1D08AB9D32 wds:Q58556107-F376D981-9C72-4D4A-9458-F79D3D378253 wds:Q58556107-F38643CB-06FF-450F-81CC-662FAB88647A wds:Q58556107-FA32AFCF-F152-4A80-95D9-B2FB7A9ADB39
cites work	Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up Treatment of hyperprolactinemia: a systematic review and meta-analysis. Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy Quality of life is decreased in female patients treated for microprolactinoma. The historical evolution of transsphenoidal surgery: facilitation by technological advances Macroprolactinoma: a diagnostic and therapeutic update Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline Endoscopic pituitary surgery: a systematic review and meta-analysis Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists Dopamine receptor agonists for treating prolactinomas Dopamine agonist-resistant prolactinomas The epidemiology of prolactinomas. Pharmacologic resistance in prolactinoma patients Cabergoline use for pituitary tumors and valvular disorders Effect of dopaminergic drug treatment on surgical findings in prolactinomas Pituitary tumor surgery: review of 3004 cases Microsurgical management of prolactinomas - clinical and hormonal outcome in a series of 172 cases. Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment Transsphenoidal surgery for microprolactinomas in women: results and prognosis Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas Endoscopic endonasal surgery for pituitary adenomas. Hyperprolactinemia and prolactinoma Update on prolactinomas. Part 2: Treatment and management strategies Surgical outcomes and prognostic factors of transsphenoidal surgery for prolactinoma in men: a single-center experience with 87 consecutive cases Quality of life in women with microprolactinoma treated with dopamine agonists Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software